Structural

Transcatheter Treatment Options and Outcomes

STS Data and Guidelines

Impact of Tricuspid Regurgitation on Clinical Outcomes: The PRIME-MR Registry

Prognostic Impact of Extra-Tricuspid Valve Involvement After Tricuspid Transcatheter Edge-to-Edge Repair: Insights from the Bronx Valve and TRISPA Registries

Defining an Optimal Result of Transcatheter Tricuspid Valve Intervention: Results From the Tri-QOL Study

TRISCEND II: Echocardiographic Outcomes One Year Post Transcatheter Tricuspid Valve Replacement

Clinical Progression in TRILUMINATE Pivotal Control Group: Insights Into Crossover to Tricuspid TEER

What Are the Next Clinical Trials Needed in the Tricuspid Space?

Are the Available Data Sufficient to Recommend Widespread Use of TTVI in Symptomatic Severe TR Patients? NO, Unblinded Patient-Reported Outcomes Are Simply Not Enough!

Are the Available Data Sufficient to Recommend Widespread Use of TTVI in Symptomatic Severe TR Patients? YES, in these Desperate Patients, Quality-of-Life Outcomes Are a Great Starting Point!

A Deep Dive Into the Quality-of-Life Evidence From TRILUMINATE and TRISCEND II

Reviewing the Main Clinical Findings From Recent TTVI Clinical Trials

TTVR: Expanding Clinical Indications and Future Trials

Bridging the Gaps: Key Takeaways from TRISCEND II

Clinical Trials Update: Real-World Tricuspid TEER Registries

Clinical Update from RCTs in Tricuspid TEER (Tri-FR and TRILUMINATE)

Patient Reported Outcomes in National Registries: Why and How?

Why We Need a "Toolbox" Approach for the Tricuspid Valve

Critical Appraisal of the FDA Trials … TRISCEND II (tricuspid TVR) – Can We Balance the Complications?

Critical Appraisal of the FDA Trials … TRILUMINATE (tricuspid-TEER) – Are PROs Enough?

The Compelling Case for Transcatheter Tricuspid Therapies

Topline Results from the TRISCEND II Transcatheter Tricuspid Valve Replacement Trial

Topline Results from the TRILUMINATE Transcatheter Tricuspid Edge-to-Edge Repair Trial

Con: Heterotopic TTVR Indications Are Limited and Should Be Considered as a Last Resort!

Pro: Heterotopic TTVR Technologies Are Evolving, thus Their Indications Will Expand!

RV Function and the Pulmonary Circulation: Physiological Insights Influencing Clinical Decision Making in TR Treatment

Assessing Functional Status and Predicting Clinical Improvement

The Importance of Baseline Hemodynamics and Tricuspid Anatomy

Real World TTVI Registries: Is There Concordance With the Randomized Trials?

T-TEER - TRILUMINATE

Transcatheter Tricuspid Valve Replacement - TRISCEND II

Impact of Tricuspid Regurgitation on Right Heart Remodeling: Insights From the TRILUMINATE Pivotal MRI and CT Imaging Substudy

The Future of Transcatheter Tricuspid Intervention: What’s Missing in Technology and Clinical Trials?

TRISCEND II: Understanding the Study Design and Interpreting the Results

The Importance of Patient Reported Outcomes in TR Clinical Studies

Patient and Device Selection Following Commercial Approval of TTVI Devices: European Perspectives

Pro-T-TEER: Safety Comes First, Risk of Replacement Outweighs the Benefits!

Pro-TTVR: Total TR Resolution Must be a Goal and is a Key Factor Impacting Long-Term Outcomes

What Have the Studies Taught Us About Transcatheter Tricuspid Valve Replacement – The Good, the Bad, and the Ugly

Experience-Based Lessons Learned from Real World T-TEER Cases

Can We Predict RV Failure After Tricuspid Intervention?

Orthotopic TTVR: What Have We Learned From the EFS studies

Quality of Life After Transcatheter Tricuspid-Valve Repair vs. Medical Therapy in Patients with Severe Tricuspid Regurgitation: Results From the Randomized TRILUMINATE Pivotal Trial

TRISCEND II: A Randomized Trial of Transcatheter Tricuspid Valve Replacement in Patients with Severe Tricuspid Regurgitation

Safety and Efficacy of a Novel Vertical Spacer with Atraumatic Anchoring for Tricuspid Regurgitation: A First-in-Man Experience (Pivot Bridge)

The CROIVALVE Duo System for the Percutaneous Treatment of Tricuspid Regurgitation: Technology and Program Update

A Novel Single-Leaflet Tricuspid Valve Replacement System (Trisol): Early Clinical Results

One-Month Outcomes of the Multicenter TRAVEL II (Transvascular Tricuspid Valve Replacement with the LuX-Valve Plus System) Study

TRILUMINATE Pivotal Imaging Substudy: Insights from CT and MRI

Validation of the Kansas City Cardiomyopathy Questionnaire in Patients With Tricuspid Regurgitation: The Tri-QOL Study

PROs are a Powerful Endpoint in TR Interventional Trials

TRILUMINATE Pivotal: Outcomes of Both Randomized and Single-arm Subjects with Transcatheter Tricuspid Valve Edge-to-Edge Repair for Tricuspid Regurgitation

Current Clinical Evidence Following TR Interventions

Case Resolution: A Patient With Severe TR and Limited Therapeutic Options

First in Human Experience with the CroiValve DUO Novel Tricuspid Coaptation Valve: THE TANDEM 1 Trial

First in Human Transfemoral TTVR with an Innovative Valve Replacement System (Topaz)

The Cardiovalve TTVR System: Human Clinical Experience (TARGET Trial)

The VDyne TTVR System: Early Human Clinical Results

PASCAL T-TEER Clinical Trial Update (CLASP IITR)

Combining the Best of Tricuspid Valve Repair & Replacement (CroiValve)

The CLASP II Trial: First 30-Day Procedural and Clinical Outcomes Report From the Roll-in Cohort

Transcatheter Tricuspid Valve Replacement: Lessons Learned from Recent Clinical Trials

Clinical Trial Data Supporting the Use of Tricuspid TEER in Symptomatic Severe TR Patients

Clinical Benchmarks for Therapy Success in Transcatheter Tricuspid Therapy